In this issue:
- FDA “Breakthrough Device Designation”
- Tox Study Completion
- WMIC 2019 Poster
- Q&A with Bob Proulx
Imagion Initiates Collaboration with Wayne State University to Develop Advanced Molecular Imaging Capabilities to Enable AI Cancer Diagnostics
August 13, 2025
Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilizing its proprietary MagSense® imaging